Add BrightSurf on Google Email

A convergence of deadly signals

A team of researchers has mapped the connections between genetic mutations and protein regulation in glioblastoma multiforme (GBM) brain cancer. They found that targeting specific transcription factors, such as SOX9 and FOXG1, could potentially treat GBM using BET bromodomain inhibitors.

SourceLudwig Institute for Cancer Research·JournalMolecular Cell·DateOct 8, 2015

Cancer genes turned off in deadly brain cancer

Scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma, a deadly type of brain tumor. The new method uses nanotechnology to deliver the microRNA across the blood-brain barrier, targeting multiple oncogenes at once and increasing cancer cell death.

SourceNorthwestern University·JournalGenes & Development·DateApr 2, 2015

Development of personalized cellular therapy for brain cancer

A preclinical study by the University of Pennsylvania School of Medicine found engineered T cells to be both safe and effective at controlling tumor growth in mice with glioblastoma. The CAR T cells target a mutation in the epidermal growth factor receptor protein called EGFRvIII, found on about 30% of glioblastoma patients' tumor cells.

SourceUniversity of Pennsylvania School of Medicine·JournalScience Translational Medicine·DateFeb 18, 2015

Scientists find important piece in the brain tumor puzzle

Researchers at McGill University have identified SUMO1 as a key player in the proliferation of glioblastoma tumour cells. The study reveals that sumoylation of CDK6 protein stabilizes it, enabling cancer stem cell growth and progression. This breakthrough could lead to targeted therapies for treating brain cancer.

SourceMcGill University·JournalNature Communications·DateJul 4, 2014

New approach makes cancer cells explode

Researchers at Karolinska Institutet have discovered a new mechanism to kill glioblastoma cells using Vacquinol-1, which causes uncontrolled vacuolization leading to cell explosion and necrosis. This approach may lead to new cancer treatments, potentially working for other cancer diseases.

SourceKarolinska Institutet·JournalCell·DateMar 20, 2014

Anti-psychotic medications offer new hope in the battle against glioblastoma

Researchers have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma. The finding is based on shRNA technology that identifies genes required for glioblastoma growth and reveals surprising links to dopamine regulation, a crucial component in treating Parkinson's disease and schizophrenia.

SourceUniversity of California - San Diego·JournalOncoTargets and Therapy·DateMar 7, 2014

Stopping tumors in their path

Researchers from McGill University have identified two transcription factors controlling the expression of genes involved in GBM tumourigenesis. Impairing these proteins could significantly reduce the ability of brain tumour-initiating cells to give rise to brain tumors.

SourceMcGill University·JournalNature Communications·DateJan 8, 2014